GLAXONSEGlaxoSmithKline Pharmaceuticals Limited· PharmaceuticalsLowNeutral
Announced Fri, 5 Jun · 20:30 IST

BRSR Report

GLAXO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.6%1-day move
₹2165.00
prior close
₹2154.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.6+0.9+0.7+1.6+0.3-3.0-2.1-2.3+1.2+13.2+11.3
Up moveDown movePending
AI summary

GlaxoSmithKline Pharmaceuticals has submitted its Business Responsibility and Sustainability Report (BRSR) to the stock exchanges. BRSR is a SEBI-mandated annual disclosure that requires listed companies to report on environmental, social, and governance (ESG) performance, including metrics on emissions, energy use, workforce diversity, employee welfare, and ethical business practices. This filing is part of routine regulatory compliance applicable to the top listed companies in India. The actual report would contain detailed ESG data covering the company's sustainability initiatives and social responsibility activities for the reporting period.

Likely market impact

This is a routine compliance filing and is unlikely to cause any significant immediate movement in the stock price. However, the underlying ESG metrics and sustainability disclosures can influence long-term investor sentiment, especially among institutional investors and ESG-focused funds.